Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice
Authors
Keywords
Thyroid, Transgenic, High resolution ultrasound, Cancer, Contrast agent
Journal
BMC MEDICAL IMAGING
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-09-13
DOI
10.1186/1471-2342-13-31
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model
- (2017) Debbie J. Lee et al. JOURNAL OF ULTRASOUND IN MEDICINE
- A Triple-Targeted Ultrasound Contrast Agent Provides Improved Localization to Tumor Vasculature
- (2017) Jason M. Warram et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Molecular Ultrasound Imaging Using a Targeted Contrast Agent for Assessing Early Tumor Response to Antiangiogenic Therapy
- (2017) Anna G. Sorace et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- Differentiated thyroid cancers: a comprehensive review of novel targeted therapies
- (2012) Katarina L Kojic et al. Expert Review of Anticancer Therapy
- Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer
- (2011) Francesco Bertolini et al. DRUG DISCOVERY TODAY
- Molecular genetics and diagnosis of thyroid cancer
- (2011) Yuri E. Nikiforov et al. Nature Reviews Endocrinology
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes
- (2010) A. Salajegheh et al. EJSO
- Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides
- (2010) J. K. Willmann et al. JOURNAL OF NUCLEAR MEDICINE
- Antiangiogenic Cancer Therapy: Monitoring with Molecular US and a Clinically Translatable Contrast Agent (BR55)
- (2010) Marybeth A. Pysz et al. RADIOLOGY
- Angiogenesis and ovarian cancer
- (2009) César Gómez-Raposo et al. Clinical & Translational Oncology
- Tumoral angiogenesis and breast cancer
- (2009) Parham Khosravi Shahi et al. Clinical & Translational Oncology
- Morphological Ultrasound Microimaging of Thyroid in Living Mice
- (2009) Marcello Mancini et al. ENDOCRINOLOGY
- Rearrangements of NTRK1 gene in papillary thyroid carcinoma
- (2009) A. Greco et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Lessons from Mouse Models of Thyroid Cancer
- (2009) Caroline S. Kim et al. THYROID
- Endoglin in angiogenesis and vascular diseases
- (2008) Peter ten Dijke et al. ANGIOGENESIS
- αvβ3 integrin and angiogenesis: a moody integrin in a changing environment
- (2008) Kairbaan Hodivala-Dilke CURRENT OPINION IN CELL BIOLOGY
- Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects
- (2008) M. Palmowski et al. MOLECULAR CANCER THERAPEUTICS
- Molecular imaging in drug development
- (2008) Jürgen K. Willmann et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted Microbubbles for Imaging Tumor Angiogenesis: Assessment of Whole-Body Biodistribution with Dynamic Micro-PET in Mice
- (2008) Jürgen K. Willmann et al. RADIOLOGY
- US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice
- (2008) Jürgen K. Willmann et al. RADIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started